SM
RXIIW
Sabby Management’s RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 RXIIW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-195,259
| Closed | -$68K | – | 123 |
|
|
2018
Q3 | $68K | Sell |
195,259
-963
| -0.5% | -$335 | 0.01% | 63 |
|
|
2018
Q2 | $49K | Sell |
196,222
-300
| -0.2% | -$75 | 0.01% | 70 |
|
|
2018
Q1 | $88K | Sell |
196,522
-1,904,275
| -91% | -$853K | 0.01% | 75 |
|
|
2017
Q4 | $273K | Hold |
2,100,797
| – | – | 0.02% | 50 |
|
|
2017
Q3 | $355K | Sell |
2,100,797
-119,695
| -5% | -$20.2K | 0.02% | 46 |
|
|
2017
Q2 | $400K | Sell |
2,220,492
-17,995
| -0.8% | -$3.24K | 0.03% | 73 |
|
|
2017
Q1 | $492K | Sell |
2,238,487
-31,796
| -1% | -$6.99K | 0.03% | 81 |
|
|
2016
Q4 | $454K | Buy |
+2,270,283
| New | +$454K | 0.03% | 92 |
|